查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1402889

肺部給藥裝置市場（產品類型：乾粉吸入器、定量吸入器和霧化器；應用：氣喘、慢性阻塞性肺病和囊性纖維化）- 2023-2031 年全球產業分析、規模、佔有率、成長、趨勢和預測

Pulmonary Drug Delivery Devices Market (Product Type: Dry Powder Inhalers, Metered Dose Inhalers, and Nebulizers; Application: Asthma, COPD, and Cystic Fibrosis) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日期: | 出版商: Transparency Market Research | 英文 170 Pages | 商品交期: 2-10個工作天內

價格

肺部給藥裝置市場 - 報告範圍

TMR 關於全球肺部藥物輸送裝置市場的報告研究了過去以及當前的成長趨勢和機會，以獲得 2023 年至 2031 年預測期內市場指標的寶貴見解。該報告提供了全球肺部藥物的收入2017- 2031 年輸送設備市場，以2023 年為基準年，2031 年為預測年。報告中也提供了2023年至2031年全球肺部給藥裝置市場的年複合成長率（CAGR %）。

該報告是經過廣泛研究後編寫的。初級研究涉及大部分研究工作，其中分析師對關鍵意見領袖、行業領導者和輿論製造者進行了採訪。二次研究涉及參考主要參與者的產品文獻、年度報告、新聞稿和相關文件，以了解肺部給藥裝置市場。

市場概況
2023年市場價值 372 億美元
2031 年市場價值 550 億美元
CAGR 4.4%

該報告深入研究了全球肺部給藥裝置市場的競爭格局。全球肺部藥物輸送裝置市場的主要參與者已經確定，並且每個參與者都根據各種屬性進行了分析。公司概況、財務狀況、最新發展和 SWOT 是本報告中介紹的全球肺部給藥設備市場參與者的屬性。

目錄

第 1 章：執行摘要

第 2 章：假設與研究方法

第 3 章：執行摘要：全球市場

第 4 章：市場概述

  • 市場區隔
  • 概述
  • 市場動態
  • 2023-2031年全球市場分析與預測

第 5 章：關鍵見解

  • 管道分析
  • 全球主要國家的疾病盛行率和發生率
  • COVID-19 大流行對該行業的影響

第 6 章：市場分析與預測：依產品類型

  • 簡介和定義
  • 主要發現/進展
  • 市場價值與銷售預測：依產品類型，2023-2031
    • 乾粉吸入器
    • 定量吸入器
    • 霧化器
  • 市場吸引力：按產品類型

第 7 章：市場分析與預測：按應用

  • 簡介和定義
  • 主要發現/進展
  • 市場價值與銷售預測：按應用分類，2023-2031
    • 氣喘
    • 慢性阻塞性肺病
    • 囊腫纖維化
    • 其他
  • 市場吸引力：按應用分類

第 8 章：全球市場分析與預測：按配銷通路

  • 簡介和定義
  • 主要發現/進展
  • 市場價值與銷售預測：依配銷通路分類，2023-2031
    • 零售藥局
    • 醫院藥房
    • 電子商務
  • 市場吸引力：按配銷通路

第 9 章：全球市場分析與預測：按地區

  • 主要發現
  • 市場價值與銷售預測：按地區，2023-2031
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 市場吸引力：按地區

第 10 章：北美市場分析與預測

第 11 章：歐洲市場分析與預測

第 12 章：亞太市場分析與預測

第 13 章：拉丁美洲市場分析與預測

第 14 章：中東和非洲市場分析與預測

第 15 章：競爭格局

  • 市場參與者 - 競爭矩陣（依公司層級和規模）
  • 市佔率分析：依公司分類（2022 年）
  • 公司簡介
    • AstraZeneca Plc
    • Novartis AG
    • Boehringer Ingelheim GmbH
    • GlaxoSmithKline Plc
    • Merck & Co., Inc.
    • Teva Pharmaceutical Industries Ltd.
Product Code: TMRGL48993

Pulmonary Drug Delivery Devices Market - Scope of Report

TMR's report on the global pulmonary drug delivery devices market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global pulmonary drug delivery devices market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global pulmonary drug delivery devices market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the pulmonary drug delivery devices market.

Market Snapshot
Market Value in 2023US$ 37.2 Bn
Market Value in 2031US$ 55 Bn
CAGR4.4%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global pulmonary drug delivery devices market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global pulmonary drug delivery devices market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global pulmonary drug delivery devices market.

The report delves into the competitive landscape of the global pulmonary drug delivery devices market. Key players operating in the global pulmonary drug delivery devices market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global pulmonary drug delivery devices market profiled in this report.

Key Questions Answered in Global pulmonary drug delivery devices Market Report:

  • What is the sales/revenue generated by pulmonary drug delivery devices across all regions during the forecast period?
  • What are the opportunities in the global pulmonary drug delivery devices market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Pulmonary Drug Delivery Devices Market - Research Objectives and Research Approach

The comprehensive report on the global pulmonary drug delivery devices market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global pulmonary drug delivery devices market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global pulmonary drug delivery devices market.

Table of Contents

1. Executive Summary

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Pulmonary Drug Delivery Devices Market

4. Market Overview

  • 4.1. Market Segmentation
    • 4.1.1. Segment Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Pulmonary Drug Delivery Devices Market Analysis and Forecast, 2023-2031

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Disease Prevalence & Incidence Rate Globally With Key Countries
  • 5.3. COVID-19 Pandemic Impact on Industry

6. Pulmonary Drug Delivery Devices Market Analysis and Forecast, by Product Type

  • 6.1. Introduction and Definitions
  • 6.2. Key Findings/Developments
  • 6.3. Market Value & Volume Forecast, by Product Type, 2023-2031
    • 6.3.1. Dry Powder Inhalers
    • 6.3.2. Metered Dose Inhalers
    • 6.3.3. Nebulizers
  • 6.4. Market Attractiveness, by Product Type

7. Pulmonary Drug Delivery Devices Market Analysis and Forecast, by Application

  • 7.1. Introduction and Definitions
  • 7.2. Key Findings/Developments
  • 7.3. Market Value & Volume Forecast, by Application, 2023-2031
    • 7.3.1. Asthma
    • 7.3.2. COPD
    • 7.3.3. Cystic Fibrosis
    • 7.3.4. Others
  • 7.4. Market Attractiveness, by Application

8. Global Pulmonary Drug Delivery Devices Market Analysis and Forecast, by Distribution Channel

  • 8.1. Introduction and Definitions
  • 8.2. Key Findings/Developments
  • 8.3. Market Value & Volume Forecast, by Distribution Channel, 2023-2031
    • 8.3.1. Retail Pharmacies
    • 8.3.2. Hospital Pharmacies
    • 8.3.3. E-Commerce
  • 8.4. Market Attractiveness, by Distribution Channel

9. Global Pulmonary Drug Delivery Devices Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value & Volume Forecast, by Region, 2023-2031
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness, by Region

10. North America Pulmonary Drug Delivery Devices Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value & Volume Forecast, by Product Type, 2023-2031
    • 10.2.1. Dry Powder Inhalers
    • 10.2.2. Metered Dose Inhalers
    • 10.2.3. Nebulizers
  • 10.3. Market Attractiveness, by Product Type
  • 10.4. Market Value & Volume Forecast, by Application, 2023-2031
    • 10.4.1. Asthma
    • 10.4.2. COPD
    • 10.4.3. Cystic Fibrosis
    • 10.4.4. Others
  • 10.5. Market Attractiveness, by Application
  • 10.6. Market Value & Volume Forecast, by Distribution Channel, 2023-2031
    • 10.6.1. Retail Pharmacies
    • 10.6.2. Hospital Pharmacies
    • 10.6.3. E-Commerce
  • 10.7. Market Attractiveness, by Distribution Channel
  • 10.8. Market Value & Volume Forecast, by Country, 2023-2031
    • 10.8.1. U.S.
    • 10.8.2. Canada
  • 10.9. Market Attractiveness Analysis
    • 10.9.1. By Product Type
    • 10.9.2. By Application
    • 10.9.3. By Distribution Channel
    • 10.9.4. By Country

11. Europe Pulmonary Drug Delivery Devices Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value & Volume Forecast, by Product Type, 2023-2031
    • 11.2.1. Dry Powder Inhalers
    • 11.2.2. Metered Dose Inhalers
    • 11.2.3. Nebulizers
  • 11.3. Market Attractiveness, by Product Type
  • 11.4. Market Value & Volume Forecast, by Application, 2023-2031
    • 11.4.1. Asthma
    • 11.4.2. COPD
    • 11.4.3. Cystic Fibrosis
    • 11.4.4. Others
  • 11.5. Market Attractiveness, by Application
  • 11.6. Market Value & Volume Forecast, by Distribution Channel, 2023-2031
    • 11.6.1. Retail Pharmacies
    • 11.6.2. Hospital Pharmacies
    • 11.6.3. E-Commerce
  • 11.7. Market Attractiveness, by Distribution Channel
  • 11.8. Market Value & Volume Forecast, by Country/Sub-region, 2023-2031
    • 11.8.1. Germany
    • 11.8.2. U.K.
    • 11.8.3. France
    • 11.8.4. Italy
    • 11.8.5. Spain
    • 11.8.6. Rest of Europe
  • 11.9. Market Attractiveness Analysis
    • 11.9.1. By Product Type
    • 11.9.2. By Application
    • 11.9.3. By Distribution Channel
    • 11.9.4. By Country/Sub-region

12. Asia Pacific Pulmonary Drug Delivery Devices Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value & Volume Forecast, by Product Type, 2023-2031
    • 12.2.1. Dry Powder Inhalers
    • 12.2.2. Metered Dose Inhalers
    • 12.2.3. Nebulizers
  • 12.3. Market Attractiveness, by Product Type
  • 12.4. Market Value & Volume Forecast, by Application, 2023-2031
    • 12.4.1. Asthma
    • 12.4.2. COPD
    • 12.4.3. Cystic Fibrosis
    • 12.4.4. Others
  • 12.5. Market Attractiveness, by Application
  • 12.6. Market Value & Volume Forecast, by Distribution Channel, 2023-2031
    • 12.6.1. Retail Pharmacies
    • 12.6.2. Hospital Pharmacies
    • 12.6.3. E-Commerce
  • 12.7. Market Attractiveness, by Distribution Channel
  • 12.8. Market Value & Volume Forecast, by Country/Sub-region, 2023-2031
    • 12.8.1. China
    • 12.8.2. Japan
    • 12.8.3. India
    • 12.8.4. Australia & New Zealand
    • 12.8.5. Rest of Asia Pacific
  • 12.9. Market Attractiveness Analysis
    • 12.9.1. By Product Type
    • 12.9.2. By Application
    • 12.9.3. By Distribution Channel
    • 12.9.4. By Country/Sub-region

13. Latin America Pulmonary Drug Delivery Devices Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value & Volume Forecast, by Product Type, 2023-2031
    • 13.2.1. Dry Powder Inhalers
    • 13.2.2. Metered Dose Inhalers
    • 13.2.3. Nebulizers
  • 13.3. Market Attractiveness, by Product Type
  • 13.4. Market Value & Volume Forecast, by Application, 2023-2031
    • 13.4.1. Asthma
    • 13.4.2. COPD
    • 13.4.3. Cystic Fibrosis
    • 13.4.4. Others
  • 13.5. Market Attractiveness, by Application
  • 13.6. Market Value & Volume Forecast, by Distribution Channel, 2023-2031
    • 13.6.1. Retail Pharmacies
    • 13.6.2. Hospital Pharmacies
    • 13.6.3. E-Commerce
  • 13.7. Market Attractiveness, by Distribution Channel
  • 13.8. Market Value & Volume Forecast, by Country/Sub-region, 2023-2031
    • 13.8.1. Brazil
    • 13.8.2. Mexico
    • 13.8.3. Rest of Latin America
  • 13.9. Market Attractiveness Analysis
    • 13.9.1. By Product Type
    • 13.9.2. By Application
    • 13.9.3. By Distribution Channel
    • 13.9.4. By Country/Sub-region

14. Middle East & Africa Pulmonary Drug Delivery Devices Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value & Volume Forecast, by Product Type, 2023-2031
    • 14.2.1. Dry Powder Inhalers
    • 14.2.2. Metered Dose Inhalers
    • 14.2.3. Nebulizers
  • 14.3. Market Attractiveness, by Product Type
  • 14.4. Market Value & Volume Forecast, by Application, 2023-2031
    • 14.4.1. Asthma
    • 14.4.2. COPD
    • 14.4.3. Cystic Fibrosis
    • 14.4.4. Others
  • 14.5. Market Attractiveness, by Application
  • 14.6. Market Value & Volume Forecast, by Distribution Channel, 2023-2031
    • 14.6.1. Retail Pharmacies
    • 14.6.2. Hospital Pharmacies
    • 14.6.3. E-Commerce
  • 14.7. Market Attractiveness, by Distribution Channel
  • 14.8. Market Value & Volume Forecast, by Country/Sub-region, 2023-2031
    • 14.8.1. GCC Countries
    • 14.8.2. South Africa
    • 14.8.3. Rest of Middle East & Africa
  • 14.9. Market Attractiveness Analysis
    • 14.9.1. By Product Type
    • 14.9.2. By Application
    • 14.9.3. By Distribution Channel
    • 14.9.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  • 15.2. Market Share Analysis, by Company (2022)
  • 15.3. Company Profiles
    • 15.3.1. AstraZeneca Plc
      • 15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.1.2. Product Type Portfolio
      • 15.3.1.3. Financial Overview
      • 15.3.1.4. SWOT Analysis
      • 15.3.1.5. Strategic Overview
    • 15.3.2. Novartis AG
      • 15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.2.2. Product Type Portfolio
      • 15.3.2.3. Financial Overview
      • 15.3.2.4. SWOT Analysis
      • 15.3.2.5. Strategic Overview
    • 15.3.3. Boehringer Ingelheim GmbH
      • 15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.3.2. Product Type Portfolio
      • 15.3.3.3. Financial Overview
      • 15.3.3.4. SWOT Analysis
      • 15.3.3.5. Strategic Overview
    • 15.3.4. GlaxoSmithKline Plc
      • 15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.4.2. Product Type Portfolio
      • 15.3.4.3. Financial Overview
      • 15.3.4.4. SWOT Analysis
      • 15.3.4.5. Strategic Overview
    • 15.3.5. Merck & Co., Inc.
      • 15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.5.2. Product Type Portfolio
      • 15.3.5.3. Financial Overview
      • 15.3.5.4. SWOT Analysis
      • 15.3.5.5. Strategic Overview
    • 15.3.6. Teva Pharmaceutical Industries Ltd.
      • 15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.6.2. Product Type Portfolio
      • 15.3.6.3. Financial Overview
      • 15.3.6.4. SWOT Analysis
      • 15.3.6.5. Strategic Overview

List of Tables

  • Table 01: Global Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Product Type, 2023-2031
  • Table 02: Global Pulmonary Drug Delivery Devices Market Volume (Million Units) Forecast, by Product Type, 2023-2031
  • Table 03: Global Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Application, 2023-2031
  • Table 04: Global Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Distribution Channel, 2023-2031
  • Table 05: Global Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Region, 2023-2031
  • Table 06: North America Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Country, 2023-2031
  • Table 07: North America Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Product Type, 2023-2031
  • Table 08: North America Pulmonary Drug Delivery Devices Market Volume (Million Units) Forecast, by Product Type, 2023-2031
  • Table 09: North America Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Application, 2023-2031
  • Table 10: North America Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Distribution Channel, 2023-2031
  • Table 11: Europe Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
  • Table 12: Europe Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Product Type, 2023-2031
  • Table 13: Europe Pulmonary Drug Delivery Devices Market Volume (Million Units) Forecast, by Product Type, 2023-2031
  • Table 14: Europe Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Application, 2023-2031
  • Table 15: Europe Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Distribution Channel 2023-2031
  • Table 16: Asia Pacific Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
  • Table 17: Asia Pacific Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Product Type, 2023-2031
  • Table 18: Asia Pacific Pulmonary Drug Delivery Devices Market Volume (Million Units) Forecast, by Product Type, 2023-2031
  • Table 19: Asia Pacific Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Application, 2023-2031
  • Table 20: Asia Pacific Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Distribution Channel, 2023-2031
  • Table 21: Latin America Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
  • Table 22: Latin America Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Product Type, 2023-2031
  • Table 23: Latin America Pulmonary Drug Delivery Devices Market Volume (Million Units) Forecast, by Product Type, 2023-2031
  • Table 24: Latin America Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Application, 2023-2031
  • Table 25: Latin America Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Distribution Channel 2023-2031
  • Table 26: Middle East & Africa Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
  • Table 27: Middle East & Africa Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Product Type, 2023-2031
  • Table 28: Latin America Pulmonary Drug Delivery Devices Market Volume (Million Units) Forecast, by Product Type, 2023-2031
  • Table 29: Middle East & Africa Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Application, 2023-2031
  • Table 30: Middle East & Africa Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Distribution Channel 2023-2031

List of Figures

  • Figure 01: Global Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, 2023-2031
  • Figure 02: Global Pulmonary Drug Delivery Devices Market Value Share Analysis, by Product Type, 2022 and 2031
  • Figure 03: Global Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 04: Global Pulmonary Drug Delivery Devices Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 05: Global Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 06: Global Pulmonary Drug Delivery Devices Market Value Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 07: Global Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Distribution Channel 2023-2031
  • Figure 08: Global Pulmonary Drug Delivery Devices Market Value Share Analysis, by Region, 2022 and 2031
  • Figure 09: Global Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 10: North America Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, 2023-2031
  • Figure 11: North America Pulmonary Drug Delivery Devices Market Value Share Analysis, by Product Type, 2022 and 2031
  • Figure 12: North America Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 13: North America Pulmonary Drug Delivery Devices Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 14: North America Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 15: North America Pulmonary Drug Delivery Devices Market Value Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 16: North America Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Distribution Channel 2023-2031
  • Figure 17: North America Pulmonary Drug Delivery Devices Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 18: North America Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 19: Europe Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, 2023-2031
  • Figure 20: Europe Pulmonary Drug Delivery Devices Market Value Share Analysis, by Product Type, 2022 and 2031
  • Figure 21: Europe America Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 22: Europe Pulmonary Drug Delivery Devices Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 23: Europe Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 24: Europe Pulmonary Drug Delivery Devices Market Value Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 25: Europe Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Distribution Channel 2023-2031
  • Figure 26: Europe Pulmonary Drug Delivery Devices Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 27: Europe Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 28: Asia Pacific Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, 2023-2031
  • Figure 29: Asia Pacific Pulmonary Drug Delivery Devices Market Value Share Analysis, by Product Type, 2022 and 2031
  • Figure 30: Asia Pacific America Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 31: Asia Pacific Pulmonary Drug Delivery Devices Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 32: Asia Pacific Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 33: Asia Pacific Pulmonary Drug Delivery Devices Market Value Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 34: Asia Pacific Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Distribution Channel 2023-2031
  • Figure 35: Asia Pacific Pulmonary Drug Delivery Devices Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 36: Asia Pacific Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 37: Latin America Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, 2023-2031
  • Figure 38: Latin America Pulmonary Drug Delivery Devices Market Value Share Analysis, by Product Type, 2022 and 2031
  • Figure 39: Latin America Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 40: Latin America Pulmonary Drug Delivery Devices Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 41: Latin America Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 42: Latin America Pulmonary Drug Delivery Devices Market Value Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 43: Latin America Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Distribution Channel, 2023-2031
  • Figure 44: Latin America Pulmonary Drug Delivery Devices Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 45: Latin America Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 46: Middle East & Africa Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, 2023-2031
  • Figure 47: Middle East & Africa America Pulmonary Drug Delivery Devices Market Value Share Analysis, by Product Type, 2023-2031
  • Figure 48: Middle East & Africa America Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 49: Middle East & Africa Pulmonary Drug Delivery Devices Market Value Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 50: Middle East & Africa Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Distribution Channel 2023-2031
  • Figure 51: Middle East & Africa Pulmonary Drug Delivery Devices Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 52: Middle East & Africa Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 53: Global Pulmonary Drug Delivery Devices Market Share Analysis, by Company (2022)